Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Board Changes

4 Sep 2015 14:30

RNS Number : 1605Y
Fitbug Holdings PLC
04 September 2015
 

Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

4 September 2015

FITBUG HOLDINGS PLC ("Fitbug" or "the Company")

Board Changes

 

Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, announces that Fergus Kee, the Company's Chairman, has today decided to step down from the Board after four years with the Company.

 

The current non-executive directors Allan Fisher, former Chairman of the Company, and David Turner, former CEO of the Company, will jointly take over the position of interim non-executive Chairman. Allan founded Holmes Place plc and David was a founder member of LA Fitness plc. The Company has commenced a search for a new Chairman and will make a further announcement in due course. The Board thanks Fergus for his commitment and significant contribution to the company and wishes him every success in the future.

 

With the recent successful fundraise and the appointment of Anna Gudmundson as CEO, Fitbug is now well placed to implement its strategy to increase sales of the Company's integrated wearable health technology offering, including Kiqplan and Fitbug Orb.

 

**ENDS**

 

 

For further information visit www.kiqplan.com or www.fitbugholdings.com contact:

 

 

Anna Gudmundson/Paul Landau

 

Fitbug Holdings Plc

020 7449 1000

Marc Milmo/Catherine Leftley

Cantor Fitzgerald Europe, Nomad and Joint Broker

 

020 7894 7000

Claire Louise Noyce/William Lynne/Niall Pearson

 

Hybridan LLP, Joint Broker

0203 764 2341 / 2342 / 2343

Elisabeth Cowell/Charlotte Heap

St Brides Partners Ltd, Public Relations

020 7236 1177

 

 

Notes

About Fitbug®

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug or Kiqplan into their own service/product offerings or resell to their customer base. The Company has operations in the UK and United States. For more information, visit www.fitbug.com and www.kiqplan.com.

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPKQDBNBKDBCK
Date   Source Headline
11th Feb 20202:06 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:05 amRNSSecond Price Monitoring Extn
11th Feb 202011:00 amRNSPrice Monitoring Extension
11th Feb 20207:15 amRNSAppointment of Andrew House to Advisory Committee
11th Feb 20207:00 amRNS2019 Year End Trading Update
10th Feb 20202:06 pmRNSSecond Price Monitoring Extn
10th Feb 20202:00 pmRNSPrice Monitoring Extension
3rd Jan 20204:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20204:35 pmRNSPrice Monitoring Extension
23rd Dec 20199:35 amRNSBlock listing Interim Review
20th Dec 20196:06 pmRNSConfirmation regarding Trading Update
19th Dec 20197:00 amRNSMilestone Advertising Trading Agreement
18th Dec 20197:00 amRNSTrading Update
17th Dec 20192:06 pmRNSSecond Price Monitoring Extn
17th Dec 20192:00 pmRNSPrice Monitoring Extension
4th Nov 201910:17 amRNSGrant of Share Options
29th Oct 201911:34 amRNSAppointment of Bryan Neider to Advisory Committee
28th Oct 20193:21 pmRNSExercise of Options and Total Voting Rights
28th Oct 201911:05 amRNSSecond Price Monitoring Extn
28th Oct 201911:00 amRNSPrice Monitoring Extension
28th Oct 201910:25 amRNSDirectors' dealings
30th Sep 20197:00 amRNSInterim results for the six months ended 30 June
27th Sep 20195:24 pmRNSStrategic Partnership with Dentsu Aegis Network
26th Sep 20197:00 amRNSExtension of Football Manager Agreement
17th Sep 201912:13 pmRNSNotice of Results
30th Aug 201911:03 amRNSTotal Voting Rights
29th Aug 20194:01 pmRNSNew contract with The Trade Desk
22nd Aug 20192:35 pmRNSChange of Broker
19th Aug 201911:45 amRNSCollaboration with Epic Games' Unreal Engine
13th Aug 20192:06 pmRNSSecond Price Monitoring Extn
13th Aug 20192:00 pmRNSPrice Monitoring Extension
12th Aug 20195:09 pmRNSBidstack signs contract with AppNexus
1st Aug 20197:00 amRNSAcquisition of Pubguard
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 20194:40 pmRNSSecond Price Monitoring Extn
11th Jul 20194:35 pmRNSPrice Monitoring Extension
11th Jul 20192:05 pmRNSSecond Price Monitoring Extn
11th Jul 20192:00 pmRNSPrice Monitoring Extension
2nd Jul 20197:00 amRNSAppointment of Derek Wise and other Board changes
24th Jun 20193:42 pmRNSResults of Independent Study by Lumen Research
11th Jun 20198:09 amRNSBlock Listing Application
11th Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
7th Jun 20197:00 amRNSIssue of Equity and Total Voting Rights
6th Jun 201910:01 amRNSExercise of Warrants and Total Voting Rights
6th Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
3rd Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
31st May 20195:04 pmRNSAppointments to Advisory Board
28th May 20199:05 amRNSSecond Price Monitoring Extn
28th May 20199:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.